Literature DB >> 30097908

Anticholinergic Drugs for Overactive Bladder in Frail Older Patients: The Case Against.

Henry J Woodford1.   

Abstract

Urinary incontinence (UI) is a common and disabling problem among older people. Anticholinergic drugs (ADs) are a pharmacological option recommended for overactive bladder or mixed UI when non-pharmacological approaches have failed. However, UI is a more prevalent and complex condition in frail older people and to simply assume that AD actions are the same across all age groups would be wrong. This article reviews evidence for the efficacy and safety of these drugs, especially when prescribed for frail older people. Although ADs have a small but statistically significant benefit for UI in non-frail people, the vast majority choose to discontinue treatment because they feel that the beneficial effects do not outweigh the burden of taking the medication. Not only are the most frail older people more likely to experience adverse effects but there is also no evidence that these drugs are effective for UI. In addition, there is a mounting body of evidence that they impair cognitive function. The continued use of ADs in frail older people simply does not hold water.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30097908     DOI: 10.1007/s40266-018-0575-x

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  38 in total

1.  Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects.

Authors:  Gary Kay; Thomas Crook; Ludmyla Rekeda; Raul Lima; Ursula Ebinger; Miguel Arguinzoniz; Michael Steel
Journal:  Eur Urol       Date:  2006-04-19       Impact factor: 20.096

2.  Does BMI, gender or age affect efficacy/tolerability of solifenacin in the management of overactive bladder?

Authors:  Linda Cardozo; Sender Herschorn; Robert Snijder; Emad Siddiqui; Christopher R Chapple
Journal:  Int Urogynecol J       Date:  2016-09-07       Impact factor: 2.894

3.  Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.

Authors:  D Staskin; G Kay; C Tannenbaum; H B Goldman; K Bhashi; J Ling; M G Oefelein
Journal:  Int J Clin Pract       Date:  2010-06-17       Impact factor: 2.503

4.  Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial.

Authors:  Thomas E Lackner; Jean F Wyman; Teresa C McCarthy; Melinda Monigold; Cynthia Davey
Journal:  J Am Med Dir Assoc       Date:  2010-10-02       Impact factor: 4.669

Review 5.  Which anticholinergic drug for overactive bladder symptoms in adults.

Authors:  Priya Madhuvrata; June D Cody; Gaye Ellis; G Peter Herbison; E Jean C Hay-Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

6.  Assessment of cognitive function of the elderly population: effects of darifenacin.

Authors:  Richard B Lipton; Ken Kolodner; Keith Wesnes
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

7.  Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.

Authors:  Michael B Chancellor; Kristen Migliaccio-Walle; Thomas J Bramley; Sham L Chaudhari; Catherine Corbell; Denise Globe
Journal:  Clin Ther       Date:  2013-10-03       Impact factor: 3.393

8.  Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database.

Authors:  Siri A Mauseth; Svetlana Skurtveit; Olav Spigset
Journal:  Acta Obstet Gynecol Scand       Date:  2013-07-11       Impact factor: 3.636

9.  Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin.

Authors:  Marloes J Tijnagel; Jeroen R Scheepe; Bertil F M Blok
Journal:  BMC Urol       Date:  2017-04-13       Impact factor: 2.264

10.  Anticholinergic drugs and risk of dementia: case-control study.

Authors:  Kathryn Richardson; Chris Fox; Ian Maidment; Nicholas Steel; Yoon K Loke; Antony Arthur; Phyo K Myint; Carlota M Grossi; Katharina Mattishent; Kathleen Bennett; Noll L Campbell; Malaz Boustani; Louise Robinson; Carol Brayne; Fiona E Matthews; George M Savva
Journal:  BMJ       Date:  2018-04-25
View more
  2 in total

Review 1.  Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.

Authors:  George Araklitis; Dudley Robinson; Linda Cardozo
Journal:  Clin Interv Aging       Date:  2020-08-25       Impact factor: 4.458

Review 2.  The diversity of neuronal phenotypes in rodent and human autonomic ganglia.

Authors:  Uwe Ernsberger; Thomas Deller; Hermann Rohrer
Journal:  Cell Tissue Res       Date:  2020-09-15       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.